Inflammation can interfere with endometrial receptivity. We examined how interleukin 1b (IL-1b) affects expression of the uterine gap junction protein connexin 43 (Cx43), which is known to be critical for embryonic implantation. We used an in vitro model of human endometrial stromal cells (ESCs), Western blotting, and a combination of validated, selective kinase inhibitors to evaluate five canonical IL-1b signaling pathways. Cx43 and two other markers of ESC differentiation (prolactin and VEGF) were inhibited predominantly via IL-1b-activated ERK1/2 and p38 MAP kinase cascades. The findings were corroborated using small interfering RNA to silence critical genes in either pathway. By contrast, upregulation of endogenous pro-IL-1a and pro-IL-1b following recombinant IL-1b treatment was mediated via the Jun N-terminal kinase pathway. The clinicopharmacological significance of our findings is that multiple signaling cascades may need to be neutralized to reverse deleterious effects of IL-1b on human endometrial function. (Endocrinology 158: 4270-4285, 2017) I n menstruating species, which include elephant shrews, fruit bats, spiny mice (1), nonhuman old-world primates, and women, the endometrium functionalis proliferates and differentiates phasically in response to fluctuating endocrine cues. The dominant ovarian steroid hormones, estradiol and progesterone, regulate endometrial growth and differentiation, in part via paracrine actions of locally produced eicosanoids (2), growth factors (3), and retinoids (4). Their key teleological objective appears to be the development of a functionally decidualized and vascularized endometrium, facilitating blastocyst attachment, invasion, placentation, fetal growth, and successful delivery (5). In the human, the decidual reaction is initiated prior to the arrival of an embryo into the uterine cavity, so-called "conceptusindependent" (6), and hence is a response to maternal hormones and autacoids. In the absence of successful implantation, the endometrium functionalis undergoes a combination of apoptosis, autophagy, and necrosis and is shed hemostatically (7). 
The endocrine and paracrine mediators of the secretory phase induce predictable morphological and biochemical changes in receptive endometrium. Although epithelial, vascular, and immune cell components all are modified, our laboratory has focused on transformation of the remarkably plastic stroma (8) . Endometrial stromal cells (ESCs) appear bipolar and fibroblastic in the proliferative phase of the cycle but accumulate glycogen and lipid and increase their cytoplasmic and nuclear volumes in the late secretory phase (9) . These cytological responses are accompanied by ultrastructural changes in interdigitating lamellar microdomains called gap junctions (10) that allow adjacent cells to communicate via the direct exchange of ions and small molecules ,1 kD in mass and ,1.2 nm in Stokes radius (11) , coupling individual decidual cells into a functional tissue (12) . In human, baboon, and mouse endometrium, connexin 43 (Cx43, GJA1) is the dominantly expressed gap junction subunit, and its expression is almost exclusively localized to the stromal compartment. Data from a conditional, uterine-selective Cx43 knockout mouse strain and small interfering RNA (siRNA) and small hairpin RNA knockdown of Cx43 in decidualized human ESCs in vitro (13, 14) support the hypothesis that connexons comprised of Cx43 hexamers mediate gap junction intercellular communication (GJIC), thereby coordinating paracrine signaling within the decidua and sustaining endometrial differentiation, blastocyst implantation, and embryo development.
Impaired endometrial decidualization is increasingly attributed to pathophysiological conditions associated with reduced fecundity and pregnancy complications. These include endometriosis, polycystic ovary syndrome, recurrent miscarriage, pre-eclampsia, and preterm birth (12, (15) (16) (17) (18) (19) (20) . Some of these clinical conditions manifest altered quantity and/or distribution of uterine Cx43 (21) (22) (23) . In 26 benign human endometrial biopsies, a trend of higher Cx43 messenger RNA (mRNA) levels in the secretory phase was observed (24) , but the fertility status of these subjects was not reported. In our crosssectional study of 12 parous controls, we noted a significant (P , 0.02) doubling of Cx43/b-actin protein ratios from the proliferative to the secretory phase. Among 24 women with or without laparoscopicallyproven endometriosis, we observed that Cx43/b-actin protein ratios in eutopic endometrium of endometriosis cases were only ;35% those of the controls (25) . Similar findings were reported in human ectopic lesions (26) and in the eutopic endometrium of baboons with experimental endometriosis compared with controls (27) . In contrast to these findings, microarray analyses in autotransplantation rat models of endometriosis indicated that Cx43 mRNA expression was more than twofold higher in ectopic lesions than in eutopic endometrium (28, 29) , but neither quantitative mRNA nor protein levels was validated.
Overexpression of proinflammatory cytokines also is well established in various causes of reduced fecundity (30) , including endometriosis (31, 32) , polycystic ovary syndrome (33) , idiopathic primary infertility (34) , and recurrent miscarriage (35) , as well as in preterm birth and other complications of pregnancy (36) . We postulated that interleukin-1b (IL-1b), derived in part from infiltrating innate immune cells, might directly impede endometrial stromal differentiation via effects on gap junction physiology and endeavored to test this hypothesis using endometrial biopsies and our well-characterized in vitro model of human ESC differentiation.
Materials and Methods

Source of human tissues
Healthy, parous women with regular menstrual cycles, who had not received hormonal therapy for at least 3 months prior to surgery, were recruited. Endometrial tissue specimens were obtained from seven participants without evidence of endometriosis or other pelvic pathology at the time of laparoscopy after providing written informed consent under an Institutional Review Board-approved study protocol (Wake Forest School of Medicine no. 00019887). Endometrial biopsies collected under sterile conditions were transported to the laboratory on ice in Dulbecco's modified Eagle medium/ Ham's F-12 (catalog no. 10-092cv; CellGro, Manassas, VA) containing 10% fetal bovine serum. Two samples, obtained in the midluteal phase of the menstrual cycle, were rinsed and fixed in 10% buffered formalin for immunohistochemistry. The remaining five specimens, collected in the midproliferative phase to avoid effects of endogenous progesterone, were used to prepare primary cell cultures as described below. Histological staging (37) confirmed the subjects' menstrual dates in all seven cases.
Immunofluorescence immunohistochemistry
The in situ localization of protein biomarkers analyzed in cultured ESCs (see later) was validated in paraffin-embedded, secretory-phase endometrial tissue sections subjected to immunofluorescence immunohistochemistry under a published protocol (25) . Five-micrometer microtomed sections were deparaffinized in xylene and rehydrated in ethanol. Antigen retrieval was performed in 10 mM sodium citrate (pH 6.0) at 100°C for 4 minutes followed by exposure to 3% hydrogen peroxide in methanol for 10 minutes to quench endogenous hydrogen peroxide activity. After rinsing in water, nonspecific binding was inhibited with Super Block (catalog no. AAA-500; ScyTek Laboratories, Logan, UT) overnight at 4°C. Sections were incubated with primary antibodies at concentrations indicated in Table 1 . The samples were incubated at room temperature for 1 hour. Staining was performed using EnVision Plus Systems (Dako, Santa Clara, CA) reagents, according to the manufacturer's protocol. Findings representative of both secretory-phase specimens are presented.
Human ESC culture, hormone treatment, kinase inhibitors, and in vitro decidualization Human ESC cultures were prepared from five proliferativephase biopsies and subcultured at least twice to eliminate contamination by macrophages or other leukocytes as described previously (25, 38) . All cultures were studied before the sixth passage to avoid cellular de-differentiation. ESC cultures prepared by this protocol were .93% pure and retain phenotypic endometrial stromal markers in vitro, including functional estrogen and progesterone receptors (38, 39) . ESCs were cultured directly on 10-cm polystyrene dishes or Laboratory-Tek glass chamber slides (catalog no. 177402; Thermo-Fisher Scientific, Waltham, MA) without exogenous extracellular matrix substrate. Cells were grown to 60% to 80% confluence in phenol red-free Dulbecco's modified Eagle medium/Ham's F-12, supplemented with 5% charcoal-stripped fetal calf serum. To induce decidualization, ESCs were subjected to an established differentiation protocol (8, 14, 25) by incubation with 10 nM 17b-estradiol, 100 nM progesterone, and 0.5 mM dibutyryl cyclic adenosine monophosphate (E/P/c) for up to 3 days.
Quantification of cell shape and number
Cell morphology was assessed every other day by phasecontrast microscopy using a modified calculation of cell "roundness" (40-42) as described previously (8) . Recombinant mature IL-1b (molecular mass = 17 kD) was purchased from Sigma-Aldrich, and IL-1 receptor antagonist (IL-1ra) was obtained from R&D Systems (catalog no. 280-R-010). ESCs were incubated in the absence or presence of E/P/c, IL-1b, and, in some cases, IL-1ra [the latter added at a 100-fold excess relative to IL-1b (43) ] for up to 3 days. Culture supernatants and cellular protein and RNA lysates were sampled at the time points indicated, as described previously (25) . Cell numbers were determined using a hemacytometer and also by detecting the reduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium dye (MTS) as reported (44) .
Scrape loading-dye transfer assays
To assess functional GJIC in cultured ESCs, we used the gap junction-permeable fluorescent dye Lucifer Yellow (Molecular Probes, Life Technologies) as described previously (45) . ESCs grown for 3 days in the absence or presence of decidualizing hormones, with or without added IL-1b, were washed thoroughly with phosphate-buffered saline (PBS), and the monolayer was sliced with a scalpel blade. Lucifer Yellow dye (1 mg/mL) was added to the scraped culture supernatant and rinsed away after 5 minutes. Following three washes with PBS, ESCs were fixed with 4% paraformaldehyde, and lateral diffusion of dye from the scrape injury was determined by fluorescence emission under an inverted microscope and measured in a minimum of five fields, each from three independent cultures (25) . Cells that incorporated Lucifer Yellow from adjacent scrape-loaded cells were considered to have GJIC. Pixel intensity using Systat software image analysis (Systat Inc., San Jose, CA) was used to quantify GJIC relative to control ESCs and expressed as mean 6 standard error of the mean percentage (Table 2) as described previously (25) .
Enzyme-linked immunosorbent assay methods
Sensitive and specific commercial sandwich enzyme-linked immunosorbent assay kits that we previously validated with ESC supernatants (14) were used to quantify prolactin (Alpha Diagnostic International, San Antonio, TX) and VEGF (R&D Biosystems, Minneapolis, MN). As others have established, the former is a classical marker of ESC decidualization (9, (46) (47) (48) , and our prior findings indicate that VEGF secretion also correlates with decidualization (14) . IL-6 was measured as a positive control for IL-1b activation (39) .
Western blot analyses
Western blots were performed on whole-cell extracts obtained by vortexing ESCs in extraction buffer (catalog no. FNN0011; Life Technologies, Grand Island, NY). Total proteins (20 to 60 mg per lane), determined using the Thermo Scientific-Pierce BCA Protein Assay Kit (catalog no. PI-23227; Thermo-Fisher Scientific), were run on NuPAGE ® Novex ® 4% to 12% Bis-Tris Protein Gels, transferred to polyvinylidene difluoride membranes, and blocked with 5% skim milk in PBS. Specific proteins were detected using curated and registered polyclonal or monoclonal antibodies at optimized concentrations, as indicated in Table 1 . After overnight labeling with the primary antisera, blots were then incubated with a secondary goat anti-rabbit or -mouse antibody (1:300 ,000) (catalog nos. 31460 and 31461; Pierce Biotechnology Inc., Rockford, IL) linked to horseradish peroxidase, and immunoreactive bands were visualized by the Enhanced Chemiluminescence System (Amersham Pharmacia Biotech, Piscataway, NJ). The size of each band is indicated in the figures. For quantification, Western blot bands were captured by laser densitomery and normalized to the intensity of corresponding, constitutive b-actin band densities for statistical analyses.
Specific inhibitors of selective kinase pathways
PD98059 (PD; ERK inhibitor), SB203580 (p38 MAPK inhibitor), and SP600125 [Jun N-terminal kinase (JNK) inhibitor] were from Sigma-Aldrich (catalog nos. P215, S8307, and S5567, respectively). Rapamycin (mTOR inhibitor) was obtained from Cell Signaling Technology (catalog no. 9904; Danvers, MA). IL-1ra, a natural inhibitor of type I and II IL-1 receptors (43) was purchased from R&D Systems (Minneapolis, MN). NF-kB inhibitory peptides and selective kinase inhibitors were used to validate the signaling pathways activated by IL-1b treatment. SN50 (catalog no. 481480; EMD-Millipore, Billerica, MA) blocks translocation of NF-kB; NBP2-29321 inhibits phosphorylation of Ser529/536, and NBP2-26505 blocks the Ser276 site of RelA/p65 (Novus Biologicals, Littleton, CO). The inert analog SN50M was used as a negative control. In all of the experiments using various kinase and NF-kB inhibitors, the inhibitory compounds were added to the cultures 1 hour prior to the addition of IL-1b. The latter was allowed to incubate for 20 minutes to 72 hours prior to termination of the studies.
RNA interference to corroborate roles of ERK1/2 and p38 MAPK in IL-1b signaling
To independently confirm our findings using selective kinase inhibitors, we used specific double-stranded siRNA constructs (Cell Signaling) to selectively silence translation of ERK1/2 (catalog no. 6560), p38 MAPK (catalog no. 6243), and a scrambled duplex control siRNA (catalog no. 6568) from the same manufacturer as a negative control. siRNAs were introduced into ESCs grown on six-well dishes by transfection with Lipofectamine RNAiMAX reagent (Thermo-Fisher Scientific) with some modifications to the manufacturer's specifications and an increase in targeted and control siRNA to 100 nmol per well.
Immunofluorescence immunocytochemistry
To corroborate and localize the expression of Cx43, selected kinases, and NF-kB family members observed in ESC lysates, their cellular distribution was analyzed in intact ESCs grown on Laboratory-Tek ® chamber slides under conditions of decidual hormone stimulation, before and after IL-1b exposure, and fixed in 4% paraformaldehyde. Immunofluorescence immunocytochemistry (ICC) was performed on an EVOS cellular imaging microscope (Thermo-Fisher Scientific).
RNA isolation and real-time reverse transcription quantitative polymerase chain reaction RNA was isolated from ESCs using the TRIzol ® Plus RNA Purification Kit (Life Technologies, Grand Island, NY) following the manufacturer's protocol. Total RNA concentrations were calculated by the NANODROP 2000 method. Complementary DNA was synthesized from mRNA samples and subsequently used as template. Real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) used BioRad SsoAdvanced™ SYBR ® Green Supermix (catalog no. 172-5271; Bio-Rad, Hercules, CA). A total reaction volume of 20 mL contained 10 mL SYBR, 1 mL primer mix, and 0.5 mL 50 mM MgCl 2 . Amplification of the Cx43 and GAPDH (control) genes was performed using proprietary primers acquired from QIAGEN according to the manufacturer's specifications and following DNase treatment of the preparations to exclude genomic DNA contamination (8) . Absence of a polymerase chain reaction product when reverse transcription was excluded from the amplification mix afforded an additional control against genomic DNA interference. The polymerase chain reaction was set for 40 cycles in a CFX Manager 3.1 real-time thermocycler (Bio-Rad Laboratories, Hercules, CA) under the following conditions: one denaturation cycle at 95°C for 5 minutes followed by 32 amplification cycles at 94°C for 15 seconds, 55°C for 30 seconds, and 72°C for 40 seconds. The data were analyzed after normalization with GAPDH mRNA levels, using the equation 2
DDct
, where ct is the cycle threshold. 
Statistical analysis
All of the data are representative examples of assays performed in three or more replicates, with each result repeated in two or three independent histological specimens or ESC isolates as described. All the data were normally distributed (Kolmogorov-Smirnov test) and are expressed as means 6 standard error of the mean. Significant differences between individual groups were accepted when Student t tests or analysis of variance (ANOVA) with Scheffé post hoc tests (two-tailed analyses) yielded P , 0.05.
Results
Endometrial tissue macrophages and stromal cells express IL-1b in situ
Immunofluorescence histochemistry of secretory-phase endometrial tissue demonstrates the complex, multicellular environment of the human uterine mucosa. Figure 1A reveals the presence of tissue macrophages (CD68+, green) interspersed within the stroma, with IL-1b expression indicated in red. The merged image represents concentrated IL-1b in extravasating and infiltrating macrophages (yellow), confirming that these cells are a particularly important source of IL-1b. The stromal distribution and amoeboid morphology of the CD68+ cells are characteristic of endometriotic tissue macrophages (49) . Diffusely positive endometrial cells (both stromal and glandular) also express IL-1b (red). 4 0 ,6-diamidino-2-phenylindole (DAPI) (blue) highlights nuclei with subnuclear epithelial vacuoles and perivascular stromal edema, typical of secretory endometrium. Similar studies, using anti-Cx43 antibodies (Fig. 1B) demonstrate strong expression of this gap junction protein concentrated in stromal (red) but not epithelial cells. In addition, CD68+ macrophages (green), distributed within the stroma, coexpress Cx43 (indicated by merged, yellow fluorescence) as reported previously for tumor-associated macrophages (50) .
Primary ESC cultures: morphometric effects of E/P/c and IL-1b in vitro
ESCs isolated from proliferative phase biopsies, passaged two times to eliminate macrophages and lymphocytes, grow on plastic in monolayer cultures with classical bipolar, mesenchymal morphology in hormone-free media (Fig. 1C,  top left panel) . The cells can be induced to undergo differentiation following incubation for 3 days in a decidualizing hormone cocktail containing E/P/c (Fig. 1C, bottom  left panel ). E/P/c-treated cells acquire characteristic epithelioid morphometry that can be measured objectively by cell shape indices (8, (40) (41) (42) (Table 2 ). Hormone stimulation with E/P/c led to a 3.8-fold increase in "roundness," 
Dye transfer assays show that IL-1b blocks functional GJIC in ESCs
Scrape loading-dye transfer experiments, as described previously (25) , indicated that the lateral, cell-to-cell diffusion of Lucifer Yellow increased 25% in cells treated for 3 days with E/P/c over controls without hormone treatment, but diffusion was reduced by 34% in ESCs exposed to IL-1b. Coincubation of IL-1b and E/P/c reduced dye diffusion to 98% control levels. Only E/P/calone and IL-1b-alone treatments differed significantly from controls, whereas E/P/c plus IL-1b differed from E/P/c ( Table 2 ; P , 0.05, ANOVA with Scheffé post hoc tests).
Biochemical effects of IL-1b on decidualized ESC hormone, cytokine, and Cx43 expression A classical biochemical indicator of endometrial stromal differentiation is the secretion of prolactin (46) . ESCs, cultured from proliferative phase biopsies for 3 days in media containing E/P/c, show a large increase in prolactin production, from below the level of enzymelinked immunosorbent assay detection (,2 mIU/mL/10 6 cells) in hormone-free media to 371 6 4 mIU/mL/10 6 cells (P , 0.01, Student t test). Without hormones, the addition of 5 ng/mL IL-1b had no effect on prolactin secretion (Fig. 2A) ; however, addition of recombinant IL1b during hormone exposure resulted in a 62% 6 3% reduction in prolactin secretion (P , 0.01, Student t test). An emerging biomarker of human endometrial stromal decidualization is the angiogenic factor VEGF (8, 13, 14) . Decidualization with E/P/c for 3 days stimulated a 23-fold increase in VEGF secretion (Fig. 2B ), but this effect was blunted 48% 6 1% by 5 ng/mL IL-1b (P , 0.05). IL-1b also showed a small inhibition of basal VEGF secretion. Dose-response experiments demonstrated an apparent half-maximal inhibitory concentration (IC 50 ) ;0.2 ng/ mL (12 pM) IL-1b (Fig. 2C) , and IL-1b was noted to stimulate IL-6 secretion from ESCs with similar pharmacokinetics and a half-maximal effective concentration of ;0.2 ng/mL (Fig. 2D) . These results are in line with the reported 4 pM K d and 57 pM K i of the human receptor as determined by [ 125 I]IL-1b binding in direct and competitive ligand assays on synovial cells (51) .
As in previous studies (8, 13, 14) , we observed high correlations among Cx43 expression, functional GJIC, and biomarkers of ESC decidualization, including prolactin and VEGF. In hormone-treated cells, Cx43 was upregulated as early as 24 hours after exposure to the E/P/c hormone cocktail as noted by Western blotting (Fig. 3A, top panel) . However, in stark contrast, we noted that the addition of 40, 60, or 80 ng/mL of recombinant IL-1b dramatically inhibited Cx43 levels and was associated with progressive increases in pro-IL-1b (31 kD) and mature IL-1b (17 kD) in washed cells (Fig. 3A, middle panel) . Appearance of pro-IL1b cannot be directly attributed to added recombinant mature (17 kD) IL-1b, but indicates auto-upregulation of the endogenous gene. Levels of b-actin were stable in these experiments (Fig. 3A, bottom panel) . We went on to evaluate Cx43 and pro-IL-1b by Western blotting of ESC lysates derived from four independent subjects (Fig. 3B) . As reported before (25) , variability in basal Cx43 expression was observed among individual ESC preparations; however, treatment with 5 ng/mL IL-1b for 24 hours consistently and significantly reduced Cx43 expression by 64% 6 11%, normalized to b-actin (P , 0.01; Fig. 3B , top panel, 43-kD bands). Addition of recombinant IL-1b also induced a robust auto-upregulation of endogenous pro-IL1b, as indicated by the appearance of 31-kD bands on Western blots in three of four ESC preparations (all but N3; Fig. 3B , top panel) from an undetectable baseline. By contrast, IL-1b treatment had no effect on b-actin expression in these cells (Fig. 3B, bottom (Fig. 3C, panel 1) . A progressive diminution of Cx43 protein expression was observed with the band being undetectable by 12 hours. This is consistent with the reported short half-life of Cx43 (52) . These experiments also revealed that pro-IL-1a (31 kD), IL-1a (17 kD), and pro-IL-1b (31 kD) were all positively autoregulated after 160 minutes of recombinant IL-1b treatment (Fig. 3C , panels 2 and 3). Generation of cleaved caspase 3, a sensitive indicator of apoptosis, was observed 48 hours after exposure to recombinant IL-1b and corresponded to near total depletion of Cx43 from the ESC lysates (Fig. 3C, panel  4) . This result was consistent with our prior observations that blockade of ESC GJIC by 18a-glycyrrhetinic acid, octanol, or small hairpin RNA targeting Cx43 all induced caspase 3 activation, terminal deoxynucleotidyltransferasemediated dUTP nick end labeling staining, sub-G 1 chromosomal ploidy, and shortened telomere length, indicators of programmed cell death (44) . b-Actin levels were not affected (Fig. 3C, panel 5 ).
IL-1b actions in ESCs are IL-1 receptor-mediated
To address the inhibitory mechanisms of IL-1b on Cx43, and to verify that the effect was receptor mediated, we performed experiments in the presence of a 100-fold molar excess of recombinant IL-1ra, an endogenous inhibitor of IL-1 type I and II receptors (43, 53) . Whereas IL-1ra alone had no apparent effect, IL-1ra neutralized the suppressive effect of IL-1b on Cx43 expression and returned levels of the gap junction protein to those of basal conditions (Fig. 3D, top  panel) . The obverse effect was noted for pro-IL-1b, which was increased by 5 ng/mL recombinant IL-1b, but blocked when IL-1ra and IL-1b were coincubated (Fig. 3D, middle  panel) . b-Actin levels were not altered (Fig. 3D, bottom  panel) . Suppression of Cx43 by IL-1b was mediated, in part, at the mRNA level, as RT-qPCR showed Cx43 transcript levels were reduced by ;40% (IC 50 ;1 ng/mL) (Fig. 3E) .
Abrogation of IL-1b-mediated inhibition of Cx43 by IL-1ra supported an IL-1 receptor-mediated mechanism of action, but to further characterize the pathway(s) responsible for IL-1b suppression of this ESC differentiation biomarker, we probed five of the canonical signaling cascades modulated by this cytokine, including the ERK-MAPK, p38 MAPK, JNK, mTOR, and NF-kB signaling pathways (53) (54) (55) (56) .
Systematic analysis of IL-1b signaling pathways using selective kinase inhibitors
Coincubation of IL-1b with PD for 24 hours, a selective MEK inhibitor that blocks phosphorylation of ERK1/2, partially reversed the fibroblastic morphology induced by IL-1b (Fig. 4A, right panels) . PD alone increased ESC "roundness" compared with control (Fig. 4A, left panels) . ICC of ESCs exposed to recombinant IL-1b for 24 hours showed a reduction in the number and intensity of punctate Cx43 foci (green) corresponding to gap junctions. Coincubation of IL-1b with PD reversed the IL-1b-mediated reduction in Cx43, and PD alone increased Cx43 (Fig. 4B, bottom left panel) . The effects of PD alone suggest that endogenous IL-1b expression in ESCs partly tempers basal morphology and Cx43 levels. Immunofluorescence staining of phospho-ERK1/2 (green) was increased following IL-1b treatment of 20 minutes, and there was a redistribution of the kinase into nuclei. Both phenomena were blunted by PD (Fig. 4C, bottom panels) . b-Actin staining (red) can be visualized faintly in the background.
Short time-course Western blot experiments (#40 minutes) demonstrated that IL-1b rapidly, and in most cases transiently, phosphorylated ERK and other kinase substrates. In particular, phospho(P)-MEK1/2, P-ERK1/2, and P-p90RSK of the MAPK signaling pathway were all induced within 20 minutes of IL-1b treatment (Fig. 4D,  panels 1-3) . P-p38MAPK, P-MSK1, both 70-and 85-kD isoforms of P-p70S6K, and P-S6 were increased within 20 to 40 minutes of cytokine stimulation (Fig. 4D, panels  4-7) . However, P-mTOR and b-actin levels were essentially unchanged (Fig. 4D, panels 8 and 9 ).
Given our ICC results (Fig. 4B ) and the prominent IL-1b effects on the ERK-MAPK pathway in ESCs, we assessed the actions of PD on Cx43 by Western blotting over a wide range of doses (data not shown). Treatment with 2 or 4 ng/mL IL-1b for 24 hours reduced Cx43, whereas coincubation with PD at 15 or 30 mM partially reversed the IL-1b-induced effects (Fig. 4E) . PD alone at those concentrations stimulated an 80% increase in Cx43 above baseline, in keeping with the ICC findings (Fig. 4B) , whereas b-actin levels were not altered (Fig. 4E, bottom  panel) . In Fig. 4F , IL-1b again profoundly inhibited Cx43. In the absence of IL-1b, PD, and SB203580 (ERK and p38 MAPK inhibitors, respectively) increased Cx43 to levels approaching E/P/c-treated ESCs, whereas SP600125 and rapamycin (JNK and mTOR inhibitors, respectively) partially suppressed Cx43. b-Actin levels remained stable.
Kinetic experiments, performed 20 minutes (Fig. 4G ) or 24 hours (Fig. 4H) after IL-1b treatment, served to validate the activity and specificity of the various inhibitors. IL-1b induced the rapid phosphorylation of MEK1/2, ERK1/2, p90RSK, MSK1, p38 MAPK, JNK, and p70S6kinase; however, P-mTOR, P-S6, and b-actin remained stable after 20 minutes (Fig. 4G ), but P-S6 was noted to be increased after 40 minutes (Fig. 4D ) and P-mTOR was increased after 24 hours (Fig. 4H ). As observed above, endogenous IL-1b was noted to be autoupregulated by recombinant IL-1b, but only the JNK inhibitor (SP600125) was capable of blunting this effect ( Fig. 4G and 4H) . Among the inhibitors, PD had the most profound effect on the ERK-MAPK cascade. PD and SB203580 partially reversed the effects of IL-1b on Cx43 at 24 hours, but had no influence on total p38, ERK, or total mTOR kinase concentrations (Fig. 4H, panels 4-6 ).
Phospho-mTOR was stimulated by IL-1b at 24 hours but was blocked by rapamycin and SP600125. ERK1/2 or p38 MAPK inhibition by PD or SB203580 further activated mTOR phosphorylation.
Inhibition of ERK1/2 promotes biomarkers of ESC differentiation
We previously showed that IL-1b attenuated biochemical indicators of decidualization [e.g., prolactin ( Fig. 2A) and VEGF (Fig. 2B) ]. In this series of experiments, addition of PD to E/P/c further enhanced prolactin (Fig. 4I) and VEGF (Fig. 4J) secretion above the effect of decidual hormones alone. In the case of VEGF, ESC ESC lysates after 20 to 40 minutes IL-1b showed increased P-MEK1/2, P-ERK1/2, P-p90RSK, P-p38MAPK, P-MSK1, P-p70S6Kinase (70-and 85-kD isoforms), and P-S6. P-mTOR and b-actin levels were unchanged. (E) Two and four nanograms per milliliter IL-1b for 24 hours reduced Cx43, whereas coincubation with 15 or 30 mM PD partially reversed effects (top panel). PD alone (15 and 30 mM) stimulated Cx43 80% above baseline (top panel). (F) IL-1b inhibited Cx43. PD and SB203580 increased Cx43 to levels approaching E/P/c-treated ESCs. SP600125 and rapamycin suppressed Cx43. b-Actin levels remained stable. (G) IL-1b increased P-MEK1/2, -ERK1/ 2, -p90RSK, -MSK1, -p38 MAPK, -JNK, and -p70S6kinase. (G, H) IL-1b auto-upregulation was only blunted by SP600125. (H) PD and SB203580 partially reversed IL-1b effects on Cx43. PD enhanced E/P/c effects on (I) prolactin (PRL) and (J) VEGF secretion (*P , 0.05). C, control. treatment with PD alone augmented production of VEGF over control conditions, suggesting that endogenous IL-1b, working via the ERK-MAPK pathway, may dampen this marker of stromal differentiation.
Confirmation using RNA interference that ERK1/2 and p38 MAPK play critical roles in IL-1b inhibition of Cx43
To corroborate the PD and SB203580 inhibitor findings by an independent method, we used siRNA to block the ERK1/2 or p38 MAPK enzymes in ESCs. Seventy-two hours after transfection of ERK1/2 siRNA, ESC morphology showed changes consistent with epithelioid morphometry of decidualized cells in the absence of hormones (Fig. 5A) . Similar findings were noted after ESC treatment with the ERK1/2 inhibitor PD (Fig. 4A,  bottom left panel) . In Western blots, the marked suppression of Cx43 by IL-1b was partially reversed when ERK1/2 or p38 MAPK were knocked down with siRNA but not by scrambled control siRNA (Fig. 5B, top panel) . The middle panels validate the effectiveness of the siRNA knockdown (68% for ERK1/2 and 53% for p38 MAPK), which explains the partial responses.
Analysis of NF-kB signaling by IL-1b in ESCs
Several experiments were performed to probe the role of NF-kB signaling in the ESC response to IL-1b. The NF-kB p65 subunit was translocated into nuclei within 20 minutes of IL-1b treatment (Fig. 6A) , consistent with the rapid proteosomal degradation of IkB reported previously in these cells (31) . This also corresponded to cytoskeletal rearrangement of b-actin and change in cell shape observed after cytokine treatment (see Fig. 1C and Fig. 4A ). The p65 subunits RelB and c-Rel are seruminducible, leucine-zipper transcription factors (57) . These, along with their 50-kD NF-kB1 and 52-kD NF-kB2 heterodimeric partner proteins (and 105-kD and 100-kD precursors, respectively) were all significantly upregulated by IL-1b in ESCs derived from four independent subjects (169% 6 11% for NF-kB1 and 162% 6 5% NF-kB2, P , 0.05; Fig. 6B , panels 1-4). Under the same conditions, b-actin levels remained stable (Fig. 6B, bottom panel) . Time-course experiments showed prompt upregulation of phospho-IKKa/b with concomitant degradation of IkBa, the major inhibitor of NF-kB, 20 to 40 minutes after incubation with IL-1b. Phospho-NF-kB p65 and total IKKa and b and reached peak levels within 40 to 160 minutes (Fig. 6C) . The effects of IL-1b on p65 and NF-kB2 could be blocked by IL-1ra (Fig. 6D) and partially by the NF-kB inhibitor SN50 at 25 mM and 50 mM concentrations (Fig. 6E) . The NF-kB inhibitors NBP2-29321 and NBP2-26505 had similar effects (data not shown). However, SN50 failed to reverse the IL-1b-induced suppression of Cx43 (Fig. 6F, panel 1, lane 4) , indicating that the NF-kB pathway does not play a major role in gap junction regulation in ESCs. Likewise, SN50 was not able to prevent the auto-upregulation of pro-IL-1b (Fig. 6G, top panel, lane 3) , implying that the auto-upregulatory effect also does not go through NF-kB. The inert mutated SN50M peptide had minimal effects on Cx43 (Fig. 6F, lanes 5 and 6) or IL-1b (Fig. 6G, lane 4) , and b-actin levels were stable. Dynamic, multifactorial model of IL-1b signaling in ESC Figure 7 represents a schematic of the IL-1b-IL-1 receptor signaling cascades in decidualizing human ESCs and their overall regulation of Cx43 and IL-1. The dominant inhibitory effect of IL-1b on Cx43 expression (and also on prolactin and VEGF secretion as shown in Fig. 4I and 4J) appears to be mediated via the ERK-MAPK signaling pathway, with some contribution from p38 MAPK, as their selective inhibitors (PD and SB203580, respectively) reverse those effects. By contrast, pro-IL-1b auto-upregulation by IL-1b appears to be predominantly mediated via the JNK pathway. Finally, NFkB, a pathway commonly attributed to the mediation of cytotoxic cytokine effects, was not a major regulator of IL-1b action in ESCs. Thus, we have identified the primary signaling mechanisms whereby IL-1b can disrupt ESC differentiation and potentially interfere with embryonic implantation.
Discussion
The process of embryonic implantation, particularly in species with deep hemochorial placentation, incites a controlled, maternal inflammatory response directed toward the semiallogeneic conceptus to ensure fetal tolerance. However, under pathophysiological conditions, wherein the host inflammatory reaction is excessive, pregnancy success can be compromised. Disorders associated with exuberant IL-1b production, including endometriosis (58), recurrent miscarriage (59), and pre-eclampsia (60), represent settings where inflammation is excessive and can lead to poor pregnancy outcomes.
Years ago, Frank et al. (61) showed that IL-1b attenuated human ESC decidualization (as detected by cell morphology and prolactin production), and HOXA10, another decidual biomarker, also was dramatically inhibited following IL-1b treatment in vitro (62) . Treatment of ESCs with metformin, a biguanide insulin sensitizer and AMP kinase activator, activated endogenous IL-1b gene expression and concomitantly reduced prolactin and IGFBP-1 secretion (63) . In the pregnant rhesus, Bethea et al. (64) showed that intra-amniotic infusion of IL-1b caused a reduction in prolactin, apparently via direct effects on decidual cells. Similar to our findings, when baboon ESCs isolated in the midsecretory phase were exposed to estradiol, a progestin and a cyclic adenosine monophosphate analog, the further addition of IL-1b resulted in a reduction in IGFBP-1 production (65). The stimulatory effects of 5 ng/mL IL-1b on p65 and NF-kB2 were blocked by 500 ng/mL IL-1ra and (E), to some extent, by the NF-kB inhibitor SN50 at 25 mM and 50 mM concentrations. (F) However, SN50 failed to reverse the IL-1b-induced suppression of Cx43. (G) Likewise, neither SN50 nor its inert mutated isoform (SN50M) were able to prevent the auto-upregulation of pro-IL-1b; b-actin levels were stable.
In our experiments, IL-1b consistently inhibited the expression of Cx43, prolactin, and VEGF proteins in E/P/ c-treated ESCs and also prevented the acquisition of their characteristic morphological transformation. An additional effect of ESC treatment with recombinant IL-1b was the auto-upregulation of endogenous pro-IL-1a and pro-IL-1b, as detected by their larger molecular weight forms on Western blots. This phenomenon was recognized previously in ESCs (66, 67) and indicates a positive feedback loop, potentially promoting a vicious cycle of endometrial inflammation. Although we did not examine its pathways comprehensively, TNF-a also was noted to have inhibitory effects on Cx43 (data not shown).
We and others have suggested that the dysregulation of endometrial gene expression and impaired decidualization associated with endometriosis may be an effect of excessive IL-1 production (58), and one genomic locus (rs6542095) replicated in endometriosis genome-wide association studies of Japanese and European ancestry is 2.5 kbp downstream of the IL-1A gene, which encodes IL-1a (68) . Peritoneal fluid of women with endometriosis is reported to have higher concentrations of IL-1a (69) , and ectopic endometriosis tissues had more IL-1b (70) and a higher ratio of active IL-1 type I/decoy IL-1 type II receptors (71) than normal endometrium.
We undertook a characterization of the enzyme cascades and mechanisms mediated by IL-1b using a combination of validated kinase antibodies and selective inhibitors of its five canonical signaling pathways. To our surprise, although acutely activated by IL-1b, the NF-kB pathway did not appear to be responsible for the cytokine's inhibitory effects on Cx43, prolactin, or VEGF production, as the NF-kB inhibitors SN50, NBP2-29321, and NBP2-26505 did not reverse the suppression of these proteins. Unlike findings reported in astrocytes (72), IL1b-mediated downregulation of Cx43 in ESCs was not effected via the JNK or mTOR pathways. By contrast, inhibition of MEK1/2 and ERK1/2 by PD or p38 MAPK by SB203580 indicated that these pathways were primarily responsible for the inhibition of Cx43. In a report from Velarde et al. (73) , the ERK inhibitor U0126 increased IGFBP-1 mRNA and protein production in decidualized ESCs and in endometriosis stromal cells, and Huang et al. (54) showed that the effects of IL-1b on COX-2 were blunted by the p38 MAPK inhibitor SB203580, but not by PD. Furthermore, when ESCs were incubated alone with the inhibitors PD or SB203580, Cx43 expression was increased significantly, and this was associated with an increase in VEGF in PD-treated cells. We validated the pharmacological kinase inhibitor Figure 7 . Schematic summary of the IL-1b-IL-1 receptor signaling cascades identified in decidualizing human ESCs. Inhibitors are indicated in red ovals, and specific phosphorylation sites are represented by green circles. The dominant inhibitory effect of IL-1b on Cx43 expression (and also on prolactin and VEGF secretion as shown in Fig. 4I and 4J) is mediated via the ERK-MAPK signaling pathway, with some contribution from p38 MAPK, as their selective inhibitors (PD and SB203580, respectively) and siRNAs reverse those effects. By contrast, pro-IL-1b auto-upregulation by IL-1b appears to be predominantly mediated via the JNK signaling pathway. Finally, NF-kB, a pathway commonly attributed to the mediation of IL-1b, and mTOR were not major regulators of the action of IL-1b in ESCs.
findings using siRNA as an alternative to knock down the ERK1/2 or p38 MAPK enzymes. In both cases, the inhibitory effects of IL-1b on Cx43 were partially reversed. These findings confirm critical roles of ERK1/2 and p38 MAPK signaling in IL-1b effects on ESC differentiation.
Curiously, the auto-upregulation of endogenous pro-IL-1a and pro-IL-1b by recombinant IL-1b is stimulated via a different pathway, involving JNK. The clinicopharmacological significance of our findings is that multiple signaling cascades may need to be neutralized to reverse negative effects of IL-1b on different aspects of uterine pathophysiology. Overall, these results support our central hypothesis that Cx43-containing gap junctions are critical for the establishment of cellular networking and ESC differentiation, ultimately providing a microenvironment for successful embryonic implantation. Pathological states associated with poor pregnancy outcomes, such as endometriosis, recurrent miscarriage, and pre-eclampsia, may reflect enhanced production and action of IL-1b, initially from infiltrating macrophages but ultimately involving synthesis from ESCs themselves. Thus, blockade of GJIC in the face of inflammation might be overcome using safe and selective small molecule inhibitors of the critical signaling pathways, such as ERK1/2 and p38 MAPK discovered in these experiments. Indeed, in a recently published double-blind, controlled trial of preconception aspirin therapy among women with elevated C-reactive protein, this low-dose, generic anti-inflammatory intervention increased the live birth rate compared with placebo (relative risk: 1.35; 95% confidence interval: 1.08 to 1.67) (74) .
